Xencor, Inc. is a clinical-stage biopharmaceutical company headquartered in Monrovia, California, specializing in the discovery and development of innovative cytokine and monoclonal antibody therapies. With a robust pipeline aimed at addressing unmet medical needs in cancer and autoimmune diseases, Xencor leverages its proprietary XmAb technology platform to enhance therapeutic efficacy and safety. The company is strategically positioned to make significant contributions to the biopharmaceutical landscape, both domestically and internationally, as it progresses its treatments through clinical development.
Click "Analyze" to generate stock analysis
XNCR Price Trend and Signals
XNCR Option Volumes & Open Interests (aggregated)
XNCR Put Call Ratios and IV (aggregated)
XNCR Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-16Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-16Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.